Friday, March 23, 2012
A drug that was known to lessen physical problems and outburst of multiple sclerosis is now seen by researchers to be a potential treatment for spinal cord injury.
In a recent study, Japanese researchers found a new hope to treat spinal cord injury in a multiple sclerosis drug which is commonly known as Gilenya. The said drug has been tested by the researchers of Jichi Medical University School of Medicine and University of Tokyo’s Graduate School of Medicine through some mice with spinal cord injury. The researchers found some motor function recovery from the mice.
Authors of the said research wrote that Gilenya, which is manufactured by Novartis, has significant treating powers. Researchers explained that spinal cord injury can worsen once swelling effects occur, therefore the drug is originally provided to reduce inflammation that happens after injury.
Moreover, authors noted that the primary activity responsible for these actions is considered to be immunological. However, their data suggests that the non-immunological functions of the drug are important as well in the treatment of spinal cord injury.
Even so, though the said study had progressed considerably, researchers still have to work on it further; as they still need to test the drug on larger animals. Nevertheless, they firmly believe that the drug will not waste their time and efforts, since they see clear hope for its potential in treating spinal cord injury.
As expected, this would definitely be a long way process before researchers eventually determine the drug’s effectiveness in treating spinal cord injury in human beings.
This is actually another great leap in getting into a higher level of discovering a better future for the victims of spinal cord injuries. The only issue arising from such research is the best time of prescribing the drug to patients.
Unfortunately, at present, studies have yet to prove that there is a drug that can protect the nervous system. The only thing that it can do is to help in the rehabilitation process.
Therefore, victims of spinal cord injury are not yet rejoicing for the said study of MS drug, but instead, they just look upon the possibility of achieving the right compensation that they deserve after being injured due to other people’s negligence.
Usually, most victims of spinal cord injury make sure that they have the best representative with years of experience like a Los Angeles personal injury attorney to help them obtain greater recovery for the injury they sustained.
Posted by LA Lawyers Journal at 4:18 PM